Stay updated on M7824 and Eribulin in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the M7824 and Eribulin in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 and Eribulin in Metastatic TNBC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T17:50:57.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The revision number updated from v3.4.1 to v3.4.2. No substantive content or public-facing information appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:53:37.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Only a site version label in the footer updated from v3.4.0 to v3.4.1; no study details, eligibility criteria, or other content were modified. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:22:46.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    UI changes add glossary display controls (Show glossary and Hide glossary) and update study record metadata to include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with Revision: v3.4.0. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' are removed.
    Difference
    0.4%
    Check dated 2026-01-22T18:08:09.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page history shows a new revision entry: Revision: v3.3.4 replacing the previous v3.3.3 in the revision log. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T05:09:33.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations section now lists Texas as a study site, replacing the prior Texas Locations listing. The HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-24T15:44:50.000Z thumbnail image

Stay in the know with updates to M7824 and Eribulin in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 and Eribulin in Metastatic TNBC Clinical Trial page.